MOGAD pathophysiology informs some of the relatively unique clinical and radiologic
features which have come to define this condition, and similarly has implications for …

ABSTRACT BACKGROUND AND PURPOSE Multiple sclerosis (MS) clinical management is
based upon lesion characterization from 2‐dimensional (2D) magnetic resonance imaging …

Introduction In multiple sclerosis (MS), inflammatory, demyelinating, and neurodegenerative
phenomena affect the spinal cord, with detrimental effects on patients' clinical disability …

Background and Goals: Multiple sclerosis (MS) is a central nervous system inflammatory
disease where magnetic resonance imaging (MRI) is an important tool for diagnosis and …

Objective: To investigate the time to diagnosis in multiple sclerosis (MS) in Germany.
Methods: Analysis of real-world registry data from the German Multiple Sclerosis Registry …

Cerebral oxygen metabolism is altered in relapsing-remitting multiple sclerosis (RRMS),
possibly a result of disease related cerebral atrophy with subsequent decreased oxygen …

Multiple sclerosis (MS) is a neurodegenerative disease with a high morbidity and disease
burden. It is characterized by the loss of the myelin sheath, resulting in the disruption of …

Abstract Purpose of Review To review the most recent advances and provide a description
of the most common autoimmune diseases causing myelitis and selective spine disorders …

Background Ischemic vasculopathy, particularly small-vessel disease, may mimic multiple
sclerosis (MS) located in the periventricular or subcortical region on magnetic resonance …

Objective To determine if vascular risk factor (VRF), that is, smoking, arterial hypertension
(HT), dyslipidaemia and diabetes, have an effect on multiple sclerosis (MS) pathology as …